Staphylococcus aureus colonizes the nasopharynx and gastrointestinal tract of humans, which represents a key risk factor for invasive diseases such as skin and bloodstream infections. Hallmarks of S. aureus are the persistent colonization of about one third of the human population and the ability to cause reiterative infections without eliciting protective immune responses. Earlier work reported that the type VII secretion system (ESS or T7bSS) is crucial for the pathogenesis of S. aureus bloodstream infections and staphylococcal escape from T cell responses. During infection, S. aureus activate dendritic cells to secrete IL-12 (p40/p70), thereby compromising the induction of adaptive immune responses due to IL-12 skewing of g- interferon-producing TH1 cells, which impede TH2 polarization and the host's ability to produce pathogen-specific antibodies. Earlier work identified genes (esaA, essA, essB and essC), whose products function as core components of the T7bSS in the staphylococcal membrane, which associate with mobile proteins (EsxA, EsxB, EsxC, EsxD and EssD) that travel the ESS pathway. One of these secretion substrates, EssD comprises a nuclease domain that cleaves DNA and promotes IL-12 secretion in myeloid cells in vivo and in vitro. We also identified new genes whose products are essential for ESS secretion. The product of essH is secreted via the Sec pathway and exhibits peptidoglycan hydrolase activity required for the assembly of the ESS pathway. Genes whose products are members of the DUF5079 and DUF5080 family represent membrane proteins that contribute to T7bSS pathway. Our proposal seeks to investigate the trafficking of the EssH effector into myeloid cells, to locate its nuclease activity in subcellular compartments of myeloid cells and to identify host signaling components required for IL-12 secretion. Other work will examine the mechanistic contributions of EssH, DUF5079 and DUF5080 proteins towards assembly and secretion of the T7bSS. Last, we will study S. aureus WU1, an ST88 isolate that adapted to persistently colonize the nasopharynx and gastrointestinal tract of mice and to cause spontaneous invasive diseases. Our experiments will explore the contributions of the ESS pathway during S. aureus WU1 persistent colonization and invasive disease in mice.

Public Health Relevance

This proposal will reveal the mechanisms whereby the Staphylococcus aureus type VII (ESS) secretion system transports the EssH nuclease effector into myeloid cells and activates signaling pathways for the secretion of IL-12. Further, we will study how ESS induction of IL-12 secretion interferes with the development of protective immune responses to support S. aureus persistent colonization and the pathogenesis of bloodstream infections in a mouse model. Experimental training of the applicant, a postdoctoral fellow committed to academic research, will be coupled with instructions in ethics, literature analysis, research presentation and grant writing, thereby establishing foundations for a life-long career in investigative studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI140643-03
Application #
9962298
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Huntley, Clayton C
Project Start
2018-07-01
Project End
2021-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Chicago
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Bobrovskyy, Maksym; Willing, Stephanie E; Schneewind, Olaf et al. (2018) EssH peptidoglycan hydrolase enables Staphylococcus aureus type VII secretion across the bacterial cell wall envelope. J Bacteriol :